Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts. Long-term results

Acta Radiol. 1999 Nov;40(6):636-8. doi: 10.3109/02841859909175601.

Abstract

Purpose: To evaluate the long-term results of single-session alcohol sclerotherapy of symptomatic benign liver cysts.

Material and methods: 23 cysts in 19 patients were treated by single-session percutaneous catheterization and injection of 96% ethanol. Evaluation of long-term results was possible in 11 cysts (volume 200-2,700 ml, mean 1,317 ml) in 11 patients. Time of observation was 12-67 months, mean 38.3 months.

Results: The reduction of volume was 93-100% (mean 98%). The re-accumulation of fluid after therapy seen in 9 patients proved to be transitory. Except for pain there were no complications.

Conclusion: Single-session sclerotherapy resulted in satisfactory cyst volume reduction in all 11 long-term follow-up patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cysts / therapy*
  • Ethanol / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Diseases / therapy*
  • Male
  • Sclerosing Solutions / therapeutic use*
  • Sclerotherapy / methods*
  • Treatment Outcome

Substances

  • Sclerosing Solutions
  • Ethanol